Plerixafor for pathogen‐agnostic treatment in murine thigh infection and zebrafish sepsis

Abstract Plerixafor is a CXCR4 antagonist approved in 2008 by the FDA for hematopoietic stem cell collection. Subsequently, plerixafor has shown promise as a potential pathogen‐agnostic immunomodulator in a variety of preclinical animal models. Additionally, investigator‐led studies demonstrated ple...

Full description

Bibliographic Details
Published in:	Clinical and Translational Science
Main Authors:	Martin O. Evans, Darren M. Smith, Adrian T. Kress, Robert J. Nadeau, Daniel J. Selig, Diana Caridha, Ratanachat Racharaks, Thomas Langowski, Michael S. Madejczyk, Chance Carbaugh, David Saunders, Mark Widder, Jason De Meese, Patricia J. Lee, Jesse P. DeLuca
Format:	Article
Language:	English
Published:	Wiley 2024-07-01
Online Access:	https://doi.org/10.1111/cts.13876

Similar Items

High throughput embryonic zebrafish test with automated dechorionation to evaluate nanomaterial toxicity.
by: Chance M Carbaugh, et al.
Published: (2022-01-01)

Beta-Lactam Probability of Target Attainment Success: Cefepime as a Case Study
by: Daniel J. Selig, et al.
Published: (2023-02-01)

Identification of Potential Sepsis Therapeutic Drugs Using a Zebrafish Rapid Screening Approach
by: Mark Widder, et al.
Published: (2024-12-01)

Plerixafor - Does it affect engraftment kinetics?
by: Satyendra Batra, et al.
Published: (2024-01-01)

A synthetic biology approach to assemble and reboot clinically relevant Pseudomonas aeruginosa tailed phages
by: Thomas Ipoutcha, et al.
Published: (2024-03-01)

Agnostic investigations
by: Gafie M.J. van Wyk
Published: (2010-11-01)

Systematic Review and Meta-Analysis of the Effect of Loop Diuretics on Antibiotic Pharmacokinetics
by: David A. Kerling, et al.
Published: (2023-05-01)

Use of plerixafor for hematopoietic stem cells mobilization in allograft donors
by: D. N. Balashov, et al.
Published: (2015-01-01)

Hematopoietic stem cell mobilization with plerixafor in sickle cell disease
by: Matthew M. Hsieh, et al.
Published: (2018-05-01)

Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone
by: Maria Rosa Lidonnici, et al.
Published: (2017-04-01)

Use of Plerixafor to Mobilize a Healthy Donor Infected with Influenza A
by: Mahmut Yeral, et al.
Published: (2018-05-01)

Plerixafor in Patients with Decreased Mobilizing Ability of Autologous Hematopoietic Stem Cells
by: MA Kucher, et al.
Published: (2016-04-01)

Outcomes of upfront plerixafor use for mobilization in germ cell tumor patients
by: Jaimie Cohen, et al.
Published: (2024-11-01)

Case Study in RefractoryNon-Hodgkin’s Lymphoma: Successful Treatment with Plerixafor
by: Hamdy Abdel Azim, et al.
Published: (2011-09-01)

Interference of daratumumab and efficacy of plerixafor on haematopoietic stem cell collection in Multiple Myeloma
by: Flavia Bigi, et al.
Published: (2024-04-01)

Agnostic geophysics
by: A. Cook
Published: (1997-06-01)

Sequence Context‐Agnostic TadA‐Derived Cytosine Base Editors for Genome‐Wide Editing in Zebrafish
by: Shaohui Zheng, et al.
Published: (2025-04-01)

Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia
by: Gail J. Roboz, et al.
Published: (2018-08-01)

P1343: TRANSPLANT OUTCOMES OF LYMPHOMA PATIENTS UNDERGOING STEM CELL MOBILIZATION WITH PLERIXAFOR
by: A. K. Gunes, et al.
Published: (2022-06-01)

ID149 Custo-efetividade do plerixafor preemptivo versus plerixafor de resgate na mobilização e coleta de células tronco hematopoiéticas em pacientes com mieloma múltiplo e linfoma
by: Roselene Mesquita Augusto Passos, et al.
Published: (2024-11-01)

Extensible Technology-Agnostic Runtime Verification
by: Christian Colombo, et al.
Published: (2013-02-01)

A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome
by: David H. McDermott, et al.
Published: (2023-10-01)

Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor
by: Naoya Uchida, et al.
Published: (2020-02-01)

Efficacy of plerixafor in CD34+ stem cell mobilization in healthy pediatric stem cell donors
by: Rishab Bharadwaj, et al.
Published: (2026-01-01)

USO DE PLERIXAFOR EM DOADORES SAUDÁVEIS DE CÉLULAS-TRONCO HEMATOPOIÉTICAS COM FALHA PRIMÁRIA DE MOBILIZAÇÃO
by: A.B. Godoi, et al.
Published: (2020-11-01)

Mass agnostic jet taggers
by: Layne Bradshaw, Rashmish K. Mishra, Andrea Mitridate, Bryan Ostdiek
Published: (2020-01-01)

Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients
by: Evgenyi Shumilov, et al.
Published: (2019-04-01)

Hematopoietic stem cell mobilization using plerixafor – single center experience at the University medical centre Ljubljana
by: Matjaž Sever, et al.
Published: (2012-12-01)

Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma
by: Surbhi Sidana, et al.
Published: (2024-10-01)

Pre-harvest platelet count predicts response to plerixafor in pediatric patients undergoing autologous stem cell transplant
by: Satyendra Batra, et al.
Published: (2024-01-01)

Successful autologous stem cell collection with filgrastim and plerixafor after long-term lenalidomide therapy for multiple myeloma
by: Rishi Agarwal, et al.
Published: (2012-12-01)

Plerixafor use in autologous hematopoietic stem cell mobilization: Experience from a single center in Southern India
by: Soumya Das, et al.
Published: (2022-01-01)

A zero-agnostic model for copy number evolution in cancer.
by: Henri Schmidt, et al.
Published: (2023-11-01)

Domain-Agnostic Representation of Side-Channels
by: Aaron Spence, et al.
Published: (2024-08-01)

Eric Perl’s Theophanism: An Option for Agnostics?
by: Travis Dumsday
Published: (2020-05-01)

Level-Agnostic Representations of Interacting Agents
by: Fernando Tohmé, et al.
Published: (2024-08-01)

Generating Topic-Agnostic Conversations With LLMs
by: Harshit Sandilya, et al.
Published: (2024-01-01)

afspm: A framework for manufacturer-agnostic automation in scanning probe microscopy
by: Nicholas J. Sullivan, et al.
Published: (2026-05-01)

Thigh Mass
by: Hong-Jen Chiou
Published: (2014-06-01)

A model-agnostic approach for understanding heart failure risk factors
by: Seyed M. Miran, et al.
Published: (2021-05-01)